Human cardiomyocyte progenitor cells: a short history of nearly everything

The high occurrence of cardiac disease in the Western world has driven clinicians and cardiovascular biologists to look for alternative strategies to treat patients. A challenging approach is the use of stem cells to repair the heart, in itself an inspiring thought. In the past 10 years, stem cells from different sources have been under intense investigation and, as a result, a multitude of studies have been published on the identification, isolation, and characterization, of cardiovascular progenitor cells and repair in different animal models. However, relatively few cardiovascular progenitor populations have been identified in human hearts, including, but not limited to, cardiosphere‐derived cells , cKit+ human cardiac stem cells , Isl1+ cardiovascular progenitors , and, in our lab, cardiomyocyte progenitor cells (CMPCs) . Here, we aim to provide a comprehensive summary of the past findings and present challenges for future therapeutic potential of CMPCs.

[1]  A. Caplan,et al.  Cultivation of rat marrow‐derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis , 2001, Journal of cellular physiology.

[2]  S. Fukuda,et al.  The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. , 2002, Blood.

[3]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[4]  M. Csete,et al.  Oxygen in the Cultivation of Stem Cells , 2005, Annals of the New York Academy of Sciences.

[5]  C. Bader,et al.  The calcineurin pathway links hyperpolarization (Kir2.1)-induced Ca2+ signals to human myoblast differentiation and fusion , 2006, Development.

[6]  Marc A. Vos,et al.  Inhibition of cardiomyocyte automaticity by electrotonic application of inward rectifier current from Kir2.1 expressing cells , 2006, Medical and Biological Engineering and Computing.

[7]  C. Bearzi,et al.  Human cardiac stem cells , 2005, Proceedings of the National Academy of Sciences.

[8]  M. Goumans,et al.  TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. , 2008, Stem cell research.

[9]  Feng Zhao,et al.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.

[10]  P. Doevendans,et al.  Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. , 2008, Stem cell research.

[11]  Alexei Degterev,et al.  Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.

[12]  D. Adams,et al.  A new tool for tissue engineers: ions as regulators of morphogenesis during development and regeneration. , 2008, Tissue engineering. Part A.

[13]  P. Vliet,et al.  Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy , 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[14]  Robert E. Poelmann,et al.  A New Direction for Cardiac Regeneration Therapy: Application of Synergistically Acting Epicardium-Derived Cells and Cardiomyocyte Progenitor Cells , 2009, Circulation. Heart failure.

[15]  P. Vliet,et al.  Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology , 2009, Nature Protocols.

[16]  Christine L Mummery,et al.  Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. , 2009, Cardiovascular research.

[17]  D. Roberts,et al.  Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages , 2009, Nature.

[18]  David L. Kaplan,et al.  Role of Membrane Potential in the Regulation of Cell Proliferation and Differentiation , 2009, Stem Cell Reviews and Reports.

[19]  Foetal and adult cardiomyocyte progenitor cells have different developmental potential , 2010, Journal of cellular and molecular medicine.

[20]  Marie-José Goumans,et al.  MicroRNA-1 and -499 Regulate Differentiation and Proliferation in Human-Derived Cardiomyocyte Progenitor Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[21]  M. Goumans,et al.  Hyperpolarization Induces Differentiation in Human Cardiomyocyte Progenitor Cells , 2010, Stem Cell Reviews and Reports.

[22]  M. Goumans,et al.  Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype. , 2010, Journal of molecular and cellular cardiology.

[23]  P. Doevendans,et al.  Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells , 2010, Journal of cellular and molecular medicine.

[24]  Gerard Pasterkamp,et al.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. , 2010, Stem cell research.

[25]  F. Conlon,et al.  Myocardial lineage development. , 2010, Circulation research.

[26]  M. Goumans,et al.  MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1 , 2010, Journal of cellular and molecular medicine.

[27]  M. Goumans,et al.  Low oxygen tension positively influences cardiomyocyte progenitor cell function , 2011, Journal of cellular and molecular medicine.

[28]  Bhanu P. Jena,et al.  Journal of Cellular and Molecular Medicine , 2014, Journal of Cellular and Molecular Medicine.

[29]  R. Bhadra,et al.  NIH Public Access , 2014 .